Results 111 to 120 of about 1,686 (194)

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels : a pilot study [PDF]

, 2018
Background: Administration of the therapeutic anti-IgE antibody omalizumab to patients induces strong increases in IgE antibody levels. Objective: To investigate the effect of intranasal administration of major birch pollen allergen Bet v 1, omalizumab ...
Bischoff, Cameron, Chan, Chanez, Christianson, Chu, Dema, Eckl-Dorna, Egger, Egger, Gevaert, Ghetie, Gieras, Hauswirth, Hayashi, Humbert, Ishizaka, Jabara, Jardieu, Kaplan, Katona, KleinJan, Laffer, Lawrence, Lowe, Lupinek, MacGlashan, Mizuma, Naclerio, Nakamura, Narayanan, Niederberger, Noga, Noga, Ota, Platts-Mills, Steinberger, Stokes, Valent   +38 more
core   +1 more source

Relationship between Airborne Cry j 1 and the Onset Time of the Symptoms of Japanese Cedar Pollinosis Patients

Allergology International, 2007
Background: Some patients with Japanese cedar (JC) pollinosis already show pollinosis symptoms before the first day of the pollen season as determined by microscopic pollen counts.
Yuichi Takahashi, Masaaki Aoyama, Masanori Yoshitake, Etsuko Abe, Nobuo Ohta, Masahiro Sakaguchi   +5 more
doaj   +1 more source

The development of a pollen information system for the improvement of QOL [PDF]

, 2001
The Kochi Prefecture Japanese Cedar and Cypress Pollen Information System (P-Net Kochi) was established in 1991 on the initiative of the Pharmaceuticals and Sanitation Division to improve the quality of life of people in Kochi Prefecture, particularly ...
1618, 50335808, 60215/profile-ja.html, Kuwada, Keizo, Matsumoto, Michiaki, Moriguchi, Hiroki, Nishimoto, Yasuo, クワダ, ケイゾウ, クワダ, ケイゾウ, ニシモト, ヤスオ, ニシモト, ヤスオ, マツモト, ミチアキ, マツモト, ミチアキ, モリグチ, ヒロキ, 森口, 博基   +14 more
core  

Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial

Allergology International, 2012
Background: Little is known about the safety and effectiveness of early interventional treatment (EIT) with intranasal corticosteroids for seasonal allergic rhinitis.
Seiichiro Makihara, Mitsuhiro Okano, Tazuko Fujiwara, Masayo Kimura, Takaya Higaki, Takenori Haruna, Yohei Noda, Kengo Kanai, Shin Kariya, Kazunori Nishizaki   +9 more
doaj   +1 more source

Antigen-Specific Immunotherapy against Allergic Rhinitis: The State of the Art

Allergology International, 2010
Allergic rhinitis is the most prevalent type I allergy in industrialized countries. Pollen scattering from trees or grasses often induces seasonal allergic rhinitis, which is known as pollinosis or hay fever. The causative pollen differs across different
Takashi Fujimura, Yoshitaka Okamoto
doaj   +1 more source

Three-Year Statistical Study of Japanese Cedar Pollinosis.

Practica Oto-Rhino-Laryngologica, 1992
Japanese cedar pollinosis was studied in 193 new outpatients (78 males, 115 females; 53 children, 140 adults) treated in our outpatient clinic from January 1987 to December 1989.Japanese cedar and Japanese cypress pollen counts changed each year. The pollen count was highest in 1988, followed by that in 1989 and then that in 1987.
openaire   +2 more sources

Effect of Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis and regulatory T cells in adults. [PDF]

Allergy, 2020
Suzuki S, Kubota N, Kakiyama S, Miyazaki K, Sato K, Harima-Mizusawa N.   +5 more
europepmc   +1 more source

Exposure to positively- and negatively-charged plasma cluster ions impairs IgE-binding capacity of indoor cat and fungal allergens [PDF]

, 2016

core   +1 more source

STUDIES ON DEVELOPMENT OF TREATMENT FOR JAPANESE CYPRESS POLLEN USING SYDOWIA JAPONICA [PDF]

, 2018
Sydowia japonica is a parasite specifically to the male strobili of Japanese cedar and a candidate for the control of Japanese cedar pollen dispersal, which is a cause of pollinosis.
山中 智博
core   +1 more source

Pollinosis [PDF]

花粉症は，花粉を抗原とする季節性アレルギー性鼻炎であり，日本においてはスギ花粉症が最も多く，2016年の東京都におけるスギ花粉症の有病率は 48.8％と推測され，その有病率は今後さらなる上昇が予想される．スギ花粉症に対する治療は，薬物療法が中心となっているが，薬物療法は症状は改善するものの治癒に至る治療法ではないため，長期の臨床効果が期待される舌下免疫療法も広く行われつつある．また，免疫療法におけるアナフィラキシーショックに代表される副作用を軽減するペプチド療法も現在開発されている．スギ花粉抗原である ...
中山, 次久
core